Washington (AP)-The administration of President Joe Biden is taking steps to expand access to Life-saving COVID-19 antiviral treatment in Paxlovid Trying to convince doctors that there are adequate supplies for people at high risk of serious illness or death from the virus.
Paxlovid, made by Pfizer, was first approved in December. The regime’s supply was initially very limited, but COVID-19 cases dropped nationwide and production increased. The White House is now continuing to raise awareness about pills and taking steps to make them more accessible.
The White House said Tuesday that it is strengthening its relationship with doctors and letting them know that they should not think twice about prescribing pills to patients. Additionally, the drug will now be distributed directly to pharmacies, in addition to existing state-run distribution channels. This is likely to increase the number of sites from 20,000 to over 30,000 per week and eventually to 40,000 locations.
The administration used the pharmacy channel to increase the availability of COVID-19 vaccines more than a year ago.
“Paxlovid is widely available in America anywhere,” Drs. Ashish Jaham, the coordinator of the White House COVID-19 response. Medications and similar antivirals “are the essential tools we will need to overcome the rest of this pandemic,” he said.
Vice President Kamala Harris, who tested positive for COVID-19 on Tuesday, picked up Paxlovid after a discussion with doctors.
Paxlovid, given within five days of symptom onset, has been shown to result in a 90% reduction in hospitalization and mortality in critically ill patients. About 300 Americans die every day from the corovirus, of which more than 2,600 have been missing for more than 2,600 years. Omicron Wave Earlier this year.
The United States has ordered an adequate supply of pills for 20 million people, which is expected to last several months. The administration warned that further delivery is contingent on Congressional approval of additional funding to respond to COVID-19. The administration warns that further delivery is contingent on Congressional approval of additional funding for addressing COVID-19.
“What we need to do is help American doctors and nurses and others who can prescribe, understand that we have a lot available and anyone who is fit and high -risk should take Paxlovid,” Jham said.
He also encouraged people who tested positive to contact their doctors to determine their authority on a drug that could prevent serious consequences.
The Food and Drug Administration has approved Pfizer for children over the age of 12 who have a positive COVID-19 test and early symptoms with an increased risk of serious consequences. This includes the elderly and those with obesity and heart disease, although the drug is not recommended for patients with severe kidney or liver problems.
The administration is also working to expand the number of test sites that provide single window virus testing for patients with COVID-19. On the ground for Paxlovid. There are currently 2,200 locations nationwide, and the administration hopes support from the Department of Health and Human Services, the Federal Emergency Management Agency, and pharmaceutical companies will allow more sites to go online at coming weeks.
Source: Huffpost
